ScholarLens Back to search
2017•European Journal of DermatologyRequires access

Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort

Laurence Bouillet, Isabelle Boccon‐Gibod, Anne Gompel, Bernard Floccard, Ludovic Martin, Claire Blanchard‐Delaunay, David Launay, O. Fain

Open publisher page 33 citations

Abstract

may be a safe and efficacious treatment option for the majority of HAE patients.

About this research paper

What this paper is about

may be a safe and efficacious treatment option for the majority of HAE patients.

Why it matters

OpenAlex reports 33 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

may be a safe and efficacious treatment option for the majority of HAE patients.

Key concepts: Hereditary angioedema, C1-inhibitor, Medicine, Angioedema, Cohort, Internal medicine, Adverse effect, Gastroenterology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert®) in a French cohort — Research Paper | ScholarLens